C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.010
+0.020 (0.67%)
At close: Feb 21, 2025, 4:00 PM
3.000
-0.010 (-0.33%)
After-hours: Feb 21, 2025, 4:45 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $212.47 million as of February 21, 2025. Its market cap has decreased by -44.77% in one year.
Market Cap
212.47M
Enterprise Value
-4.83M
1-Year Change
-44.77%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $212.47M, a decrease of -72.50%. That is a compound annual growth rate of -25.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 212.47M | -16.39% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |